The North America pharmaceutical water market size surpassed USD 16.62 billion in 2025 and is predicted to reach around USD 35.88 billion by 2035, registering a CAGR of 8% from 2026 to 2035. The market is mainly influenced by strict regulatory requirements (FDA) for high-purity water, a notable increase in biologics and pharmaceutical production, and a growing elderly population that boosts drug demand.

North America Pharmaceutical Water Market Statical Scope

The North American market is crucial as it guarantees the safety, effectiveness, and purity of drug products by providing high-quality water needed for manufacturing, cleaning, and formulating active ingredients. North America holds the leading revenue share, fueled by the increasing need for biologics/injectables, an aging population that requires medications, and stringent regulatory standards (FDA) that call for advanced purification technologies. The swift growth in biologics, vaccines , and personalized medicine requires large quantities of ultrapure water for production, establishing the market as a key supplier. Strict regulations require highly purified water (WFI, Purified Water) to avoid contamination, making it essential for compliance. The market fosters innovation in Reverse Osmosis (RO) and Ultraviolet (UV) technologies for sterilization and purification.

North America Pharmaceutical Water Market, By Type, 2025 (%)

• HPLC Grade Water - The HPLC-grade water segment plays a vital role in the North America Market, with a share of 38%, as it guarantees the precision, consistency, and sensitivity of high-performance liquid chromatography (HPLC) tests, which are necessary for confirming drug authenticity and adhering to strict quality standards.

• Water for Injection (WFI) - Water for Injection (WFI), with a share of 62%, is essential in the market because it is crucial for producing sterile injectable drugs, vaccines, and biologics. WFI meets strict regulations, prevents contaminants like bacterial endotoxins from entering the bloodstream, and supports the rapidly growing biopharmaceutical sector, holding the largest market share.

North America Pharmaceutical Water Market, By Application, 2025 (%)

• Pharmaceutical & Biotechnology Companies - The pharmaceutical & biotechnology companies segment, with a share of 72%, leads the North American market, capturing the largest share. This segment is important due to the high demand for high-purity water, needed for producing, formulating, and cleaning biologics, vaccines, and injectables.
• Academics & Research Laboratories - The Academics & Research Laboratories segment, with a share of 28%, is significant in the North American market, fueled by intense research and development in biotechnology, drug discovery, and strict regulatory compliance (GLP). This segment requires high-purity water for sensitive applications, including cell culture, analytical testing, and molecular biology.

Top Companies in the North America Pharmaceutical Water Market

• Merck KGaA
• B. Braun Melsungen AG
• Thermo Fisher Scientific, Inc.
• Cytiva (Danaher)
• Fresenius Kabi AG
• Pfizer, Inc.
• CovaChem, LLC
• Intermountain Life Sciences

Segments Covered in the Report

By Type

• HPLC Grade Water
• Water for Injection

By Application

• Pharmaceutical & Biotechnology Companies
• Academics & Research Laboratories